HIST1H2BC (Ab-20) is a rabbit-derived polyclonal antibody designed to detect the human HIST1H2BC protein, with cross-reactivity observed in mouse samples . Key specifications include:
The antibody recognizes an epitope within the N-terminal region of HIST1H2BC (residues near K20), a region critical for post-translational modifications like acetylation and ubiquitination . This specificity is supported by:
Cross-reactivity studies showing no binding to trypsin-digested chromatin fragments, confirming dependence on intact N-terminal residues .
Validated in multiple experimental workflows:
Cross-Reactivity: Mouse (validated in liver and kidney tissues) .
No Reactivity: Drosophila H2B variants (due to N-terminal sequence divergence) .
HIST1H2BC is a core histone involved in:
Chromatin Organization: Nucleosome assembly and DNA compaction .
Gene Regulation: Modulates transcription via histone code interactions .
Disease Relevance: Dysregulation linked to cancer progression and immune responses .
The Ab-20 antibody facilitates studies on:
HIST1H2BC is a core component of nucleosomes, the fundamental units of chromatin. As part of the histone H2B family, it plays a critical role in DNA packaging and gene regulation. HIST1H2BC is involved in chromatin structure maintenance, which directly impacts gene expression, DNA repair, and replication processes .
The protein is particularly important in maintaining proper chromosome organization, and its modifications (such as acetylation, ubiquitination, and 2-hydroxyisobutyrylation) are key regulators of chromatin accessibility .
The HIST1H2BC (Ab-20) Antibody (PACO59665) is a rabbit polyclonal antibody specifically designed for detecting the HIST1H2BC protein. Key specifications include:
Parameter | Specification |
---|---|
Host Species | Rabbit |
Tested Applications | ELISA, WB |
Recommended Dilutions | ELISA: 1:2000-1:10000, WB: 1:100-1:1000 |
Species Reactivity | Human, Mouse |
Immunogen | Peptide sequence around site of Lys (20) derived from Human Histone H2B type 1-C/E/F/G/I |
Form | Liquid |
Storage Buffer | Preservative: 0.03% Proclin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 |
Purification Method | Antigen Affinity Purified |
Clonality | Polyclonal |
Isotype | IgG |
Conjugate | Non-conjugated |
This antibody is designed to recognize the region surrounding lysine 20 (K20) of HIST1H2BC, which is a site known to undergo post-translational modifications .
The HIST1H2BC (Ab-20) antibody specifically targets the region around lysine 20 (K20) of human Histone H2B type 1-C/E/F/G/I. This specificity is important because:
K20 acetylation (H2BK20ac) represents a distinct post-translational modification that can be used to distinguish active enhancers from other candidate cis-regulatory elements .
Unlike antibodies targeting other regions such as H2BK5ac (EP857Y or D5H1S), H2BK11ac, or H2BK108 2-hydroxyisobutyrylation, the Ab-20 antibody provides specific information about the K20 modification state .
The difference in target epitope allows researchers to investigate distinct regulatory pathways, as different lysine modifications on H2B correlate with varying transcriptional outcomes .
It's worth noting that antibody specificity should be validated experimentally, as cross-reactivity can occur between histone modification sites due to sequence similarities .
The HIST1H2BC (Ab-20) Antibody has been validated for the following applications:
Western Blot (WB): Successfully detects HIST1H2BC in whole cell lysates from various cell lines including 293 cells. The recommended dilution range is 1:100-1:1000 .
Enzyme-Linked Immunosorbent Assay (ELISA): Can be used at dilutions of 1:2000-1:10000 for detection of HIST1H2BC in solution-phase samples .
Unlike some other HIST1H2BC antibodies (such as Ab-16), the Ab-20 variant has not been extensively validated for immunohistochemistry (IHC) or immunofluorescence (IF) applications according to the available data .
Based on optimized protocols for histone antibodies, the following Western blot procedure is recommended:
Sample Preparation:
Lyse cells with RIPA buffer followed by brief sonication
Determine protein concentration by BCA assay
Mix with loading buffer and boil at 100°C for 5 minutes
Use 10-15 μg of total protein per lane
Electrophoresis and Transfer:
Separate proteins on 15% SDS-PAGE gel (optimal for low molecular weight histones)
Transfer to PVDF membrane at 100V for 1 hour in cold transfer buffer
Antibody Incubation:
Block membrane with Odyssey Blocking Buffer for 1.5 hours at room temperature
Incubate with HIST1H2BC (Ab-20) Antibody at 1:500 dilution overnight at 4°C
Wash 3× with TBST
Incubate with appropriate secondary antibody (anti-rabbit IgG) for 1 hour at room temperature
Detection:
Visualize using chemiluminescence or fluorescence-based detection systems
Expected band size for HIST1H2BC: 14 kDa
Controls:
When encountering weak or non-specific signals with HIST1H2BC (Ab-20) Antibody, consider the following troubleshooting steps:
For weak signals:
Increase antibody concentration (try 1:100 dilution)
Extend primary antibody incubation time to 24-48 hours at 4°C
Enhance signal using more sensitive detection reagents
Increase protein loading (up to 20-25 μg for whole cell lysates)
Optimize extraction methods for better histone recovery
For non-specific bands:
Increase blocking time or concentration (5% milk or BSA)
Perform additional washes with higher stringency (0.1-0.3% Tween-20)
Reduce antibody concentration (try 1:1000 dilution)
Use freshly prepared samples to minimize degradation products
Pre-adsorb antibody with non-specific proteins
Cross-reactivity issues:
Background reduction:
The HIST1H2BC (Ab-20) Antibody provides valuable tools for investigating H2B modifications in chromatin research:
Chromatin Immunoprecipitation (ChIP) Assays:
This antibody can be used to identify genomic regions where HIST1H2BC with K20 modifications are enriched
Protocols should be optimized for histone modifications, using crosslinking times of 10-15 minutes and sonication conditions that yield 200-500 bp DNA fragments
ChIP-seq analysis can reveal genome-wide distribution patterns of modified HIST1H2BC
Co-Immunoprecipitation (Co-IP):
Can be used to identify protein complexes that interact with K20-modified HIST1H2BC
Particularly useful for studying enzymes that add or remove this modification
Analysis of Enhancer Activity:
Investigating Transcriptional Regulation:
Research has identified several connections between HIST1H2BC modifications and disease:
Cancer Biology:
Altered expression of HIST1H2BC and related variants has been observed in endocrine-resistant breast cancer
Studies show that histone H2B variants, including HIST1H2BC, are hypomethylated in estrogen deprivation-resistant cells compared to parental MCF-7 cells
Both overexpression and downregulation of H2B variants can affect cell proliferation, suggesting the need for tightly controlled expression
Metabolic Regulation:
H2B degradation plays essential roles in gene expression under reduced insulin/IGF signaling
Blocking H2B degradation in daf-2 mutant animals (insulin/IGF receptor mutants) leads to failure in dauer formation and larval lethality
This suggests a critical role for H2B regulation in metabolic adaptation
Epigenetic Dysregulation:
Modifications at specific lysine residues (including K20) can affect transcriptional programs
Aberrant histone modifications may contribute to various pathological conditions by altering gene expression profiles
Research has linked mutations in histone modification enzymes to Alzheimer's disease and congenital heart disease
Research has revealed important functional consequences of HIST1H2BC modifications:
Ubiquitination:
H2B ubiquitylation at K123 (corresponding to human K120) is linked to gene activation
Studies show that mutation of this ubiquitylation site reduces expression of specific genes, such as GAL1 (reduced 4-fold) and SUC2 (reduced to 40% of wild-type levels)
The Rad6/Bre1 complex, which mediates this ubiquitylation, localizes at transcribed genes, suggesting a role in transcription elongation
Deubiquitylation by the SAGA complex component Ubp8 is also important for proper gene regulation
Acetylation:
H2B N-terminal acetylation (H2BNTac), including at K20, distinctively marks active enhancers
These modifications strongly correlate with each other (Spearman's ρ = 0.84-0.93) but show modest correlation with H3K27ac, H3K9ac, and MED1
CBP/p300 catalytic activity is involved in H2BNTac, as demonstrated by reduced H2BNTac upon treatment with the CBP/p300 inhibitor A-485
H2BNTac is deacetylated by histone deacetylases (HDACs) 1 and 2
2-Hydroxyisobutyrylation:
When selecting between different H2B antibodies, researchers should consider:
Epitope Specificity:
Validated Applications:
Cross-Reactivity Profiles:
Species Reactivity:
Proper experimental controls are essential when working with histone antibodies:
Positive Controls:
Negative Controls:
Secondary antibody only control (omit primary antibody)
Isotype control (rabbit IgG at equivalent concentration)
Cell lines with HIST1H2BC knockdown (using shRNA or CRISPR)
Specificity Controls:
Peptide competition assay using the immunizing peptide
Comparison with other H2B antibodies targeting different epitopes
Testing antibody reactivity against purified histones or recombinant HIST1H2BC
Loading Controls for Western Blot:
To confirm antibody specificity in your experimental system:
Peptide Competition Assay:
Pre-incubate the antibody with excess immunizing peptide
A specific signal should be significantly reduced or eliminated
Knockdown/Knockout Validation:
Mass Spectrometry Validation:
Cross-Reactivity Testing:
Comparison with Other Antibodies:
This antibody provides valuable tools for several cutting-edge epigenetic research applications:
Chromatin State Mapping:
Use in ChIP-seq to map the genome-wide distribution of K20-modified HIST1H2BC
Integrate with other histone modification data to define chromatin states
Research shows that H2BNTac sites distinctively mark active enhancers and can be used to discriminate them from other candidate cis-regulatory elements
Multi-Omics Integration:
Enzyme Function Studies:
Developmental Biology:
Several cutting-edge techniques can enhance research using this antibody:
CUT&RUN and CUT&Tag:
These techniques offer advantages over traditional ChIP by providing higher signal-to-noise ratios and requiring fewer cells
Can be adapted for HIST1H2BC (Ab-20) Antibody to map K20 modifications with greater precision
Single-Cell Epigenomics:
Combining HIST1H2BC antibody with single-cell techniques can reveal cell-to-cell variation in histone modifications
Particularly valuable for heterogeneous samples such as tumor tissues
Live Cell Imaging:
Using derived intrabodies or nanobodies based on HIST1H2BC (Ab-20) for tracking dynamics of K20 modifications in living cells
Proximity Ligation Assay (PLA):
Can detect interactions between HIST1H2BC and other proteins in situ
Useful for studying protein complexes involved in adding or removing K20 modifications
CRISPR Screens Combined with Antibody-Based Readouts:
Use CRISPR libraries to identify genes affecting HIST1H2BC K20 modification
Screen for enzymes or regulatory factors using the antibody as a readout
Research has revealed important relationships between HIST1H2BC modifications and other histone marks:
Correlation with Other Histone Modifications:
H2BNTac sites (including K20ac) extensively overlap with each other (84-96%)
Most strongly marked H2BNTac regions are also marked with H3K27ac
H2BK5ac, H2BK12ac, H2BK16ac, and H2BK20ac strongly correlate with each other (Spearman's ρ = 0.84-0.93) but show modest correlation with H3K27ac, H3K9ac, and MED1
Sequential Modification Mechanisms:
Coordinated Regulation:
Cross-talk Between Different Histone Types:
This integrated network of histone modifications forms the basis of the histone code, which regulates gene expression in response to cellular and environmental signals.